Blackstone Group »

Amicus Therapeutics shares owned by Blackstone Group

Quarter-by-quarter ownership of Amicus Therapeutics (FOLD) shares owned by Blackstone Group from 13F filings

Historical chart of Blackstone Group investment in Amicus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Amicus Therapeutics held by Blackstone Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amicus Therapeutics by Blackstone Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $35M 2.5M 14.19

More positions owned by Blackstone Group

Cheniere Energy Partners Com Unit (CQP)
Energy Transfer Com Ut Ltd Ptn (ET)
Corebridge Finl (CRBG)
Gates Indl Corp Ord Shs (GTES)
FirstEnergy (FE)
Chesapeake Energy Corp (CHK)
Cheniere Energy Com New (LNG)
PG&E Corporation (PCG)
MPLX Com Unit Rep Ltd (MPLX)
Targa Res Corp (TRGP)
Enterprise Products Partners (EPD)
Bumble Com Cl A (BMBL)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Western Midstream Partners L Com Unit Lp Int (WES)
Plains All Amern Pipeline L Unit Ltd Partn (PAA)

View all positions for Blackstone Group

Top funds holding Amicus Therapeutics

Vanguard Group
Perceptive Advisors
venBio Select Advisor
Jpmorgan Chase & Co
Wellington Management Company
Redmile Group
William Blair Investment Management
Henderson Group
Palo Alto Investors
Deutsche Bank Aktiengesellschaft
Fiera Capital Corporation
Artal Group
Bank of America Corporation
Norges Bank Investment Management
Blackstone Group

View all funds holding Amicus Therapeutics